Subscribe
David Ewing Duncan, Author, NPR Correspondent, The Daily Beast Columnist & CEO of ARC Fusion: Uniting the Potential of Life Sciences, Health & Tech

What 2 Know

David Ewing Duncan, Author, NPR Correspondent, The Daily Beast Columnist & CEO of ARC Fusion: Uniting the Potential of Life Sciences, Health & Tech

The life sciences field is exciting and rapidly evolving. This week Author of , Chief Correspondent at NPR , Columnist at The Daily Beast), and CEO of ARC Fusion, David…
December 21, 2017
ADVERTISEMENT
CNS Summit

David Ewing Duncan, Author, NPR Correspondent, The Daily Beast Columnist & CEO of ARC Fusion: Uniting the Potential of Life Sciences, Health & Tech

The life sciences field is exciting and rapidly evolving. This week Author of When I’m 164, Chief Correspondent at NPR , Columnist at The Daily Beast), and CEO of ARC Fusion, David Ewing Duncan, discusses what’s exciting in the field, how using life sciences, health and tech can extend life and what that means.

ADVERTISEMENT
CNS Summit

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

Subscribe to Health Podcast Network and never miss new Episodes!

Proudly supported by:

cover
Mary Ellen Beliveau shares how her daughter’s battle with congenital heart disease drove her to improving the delivery of value-based care Join us as Mary Ellen talks about starting Knowledge to Practice (K2P) – a subscription-based educational platform that empowers frontline teams to deliver the best quality care to their patients.